EUVIMEDEUVIMED entdecken
Open Access

Isorhamnetin Exerts Antifibrotic Effects by Attenuating Platelet-Derived Growth Factor-BB-induced HSC-T6 Cells Activation via Suppressing PI3K-AKT Signaling Pathway

Mojtaba Rashidi, Emad Matour, Hasti Beheshti Nasab, Maryam Cheraghzadeh, Elham Shakerian

Iranian Biomedical Journal · 2023

DOI: 10.61186/ibj.3948 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Iranian Biomedical Journal, 2023. Verfasst von Mojtaba Rashidi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cellular and Molecular Research Center, Medical Basic Science Research Institute, Department of Clinical Biochemistry, School of Medicine, Ahvaz Jund…. Hauptthemen laut MEDLINE: Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktAnimalsRatsBecaplerminLiver CirrhosisSignal TransductionQuercetin

Stichwörter der Autor:innen

HepatitisLiver injuriesPI3K-AKT

Substanzen

BecaplerminPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akt3-methylquercetinQuercetin

Autor:innen und Institutionen

  • Cellular and Molecular Research Center, Medical Basic Science Research Institute, Department of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Zitieren

APA

Rashidi, M., Matour, E., Beheshti Nasab, H., Cheraghzadeh, M., & Shakerian, E. (2023). Isorhamnetin Exerts Antifibrotic Effects by Attenuating Platelet-Derived Growth Factor-BB-induced HSC-T6 Cells Activation via Suppressing PI3K-AKT Signaling Pathway. Iranian Biomedical Journal. https://doi.org/10.61186/ibj.3948

Vancouver

Rashidi M, Matour E, Beheshti Nasab H, Cheraghzadeh M, Shakerian E. Isorhamnetin Exerts Antifibrotic Effects by Attenuating Platelet-Derived Growth Factor-BB-induced HSC-T6 Cells Activation via Suppressing PI3K-AKT Signaling Pathway. Iranian Biomedical Journal. 2023. doi:10.61186/ibj.3948

BibTeX
@article{Rashidi2023,
  author = {Rashidi, Mojtaba and Matour, Emad and Beheshti Nasab, Hasti and Cheraghzadeh, Maryam and Shakerian, Elham},
  title = {Isorhamnetin Exerts Antifibrotic Effects by Attenuating Platelet-Derived Growth Factor-BB-induced HSC-T6 Cells Activation via Suppressing PI3K-AKT Signaling Pathway},
  journal = {Iranian Biomedical Journal},
  year = {2023},
  doi = {10.61186/ibj.3948}
}
Kostenlos starten →